Uranium Royalty Corp. Common Stock
Here’s whether Uranium Royalty Corp. Common Stock (UROY) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Positives: RSI 55 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-6.77% over 10 days); 3-month momentum negative (-21.1%); rising volume on a downtrend (distribution, 1.23x avg). Currently 46.4% off its 52-week high. Score: -4/7.
UROY is trading below its 200-day MA ($3.74) — a key warning sign the longer-term trend is under pressure. An RSI of 55.1 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -3.0% compares to +16.5% for SPY (trailed the market by 19.4%). The current 46.4% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.